References
- Amanatullah DF, Tamaresis JS, Chu P, Bachmann MH, Hoang NM, Collyar D, Mayer AT, West RB, Maloney WJ, Contag CH, et al. Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells. Breast Cancer Res. 2017 Dec;19(1):121. https://doi.org/10.1186/s13058-017-0910-x
- Arroyo R, Martín V, Maldonado A, Jiménez E, Fernández L, Rodríguez JM. Treatment of infectious mastitis during lactation: antibiotics versus oral administration of lactobacilli isolated from breast milk. Clin Infect Dis. 2010 Jun 15;50(12):1551–1558. https://doi.org/10.1086/652763
- Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B, Rogers AB, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012 Oct 05;338(6103):120–123. https://doi.org/10.1126/science.1224820
- Banerjee S, Tian T, Wei Z, Shih N, Feldman MD, Peck KN, DeMichele AM, Alwine JC, Robertson ES. Distinct microbial signatures associated with different breast cancer types. Front Micro-biol. 2018 May 15;9:951. https://doi.org/10.3389/fmicb.2018.00951
- Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014 Mar;157(1):121–141. https://doi.org/10.1016/j.cell.2014.03.011
- Bobin-Dubigeon C, Luu HT, Leuillet S, Lavergne SN, Carton T, Le Vacon F, Michel C, Nazih H, Bard JM. Faecal microbiota composition varies between patients with breast cancer and healthy women: a comparative case-control study. Nutrients. 2021 Aug 05; 13(8):2705. https://doi.org/10.3390/nu13082705
- Bouchard DS, Seridan B, Saraoui T, Rault L, Germon P, Gonzalez-Moreno C, Nader-Macias FME, Baud D, François P, Chuat V, et al. Lactic acid bacteria isolated from bovine mammary microbiota: potential allies against bovine mastitis. PLoS One. 2015 Dec 29;10(12):e0144831. https://doi.org/10.1371/journal.pone.0144831
- Braden A, Stankowski R, Engel J, Onitilo A. Breast cancer bio-markers: risk assessment, diagnosis, prognosis, prediction of treatment efficacy and toxicity, and recurrence. Curr Pharm Des. 2014 Aug 31;20(30):4879–4898. https://doi.org/10.2174/1381612819666131125145517
- Bullerdiek J, Rommel B. Factors targeting MED12 to drive tumorigenesis? F 1000 Res. 2018;7:359. https://doi.org/10.12688/f1000research.14227.2
- Claesson MJ, Jeffery IB, Conde S, Power SE, O’Connor EM, Cusack S, Harris HMB, Coakley M, Lakshminarayanan B, O’Sullivan O, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012 Aug;488(7410):178–184. https://doi.org/10.1038/nature11319
- Di Modica M, Gargari G, Regondi V, Bonizzi A, Arioli S, Belmonte B, De Cecco L, Fasano E, Bianchi F, Bertolotti A, et al. Gut microbiota condition the therapeutic efficacy of trastuzumab in HER2-positive breast cancer. Cancer Res. 2021 Apr 15;81(8): 2195–2206. https://doi.org/10.1158/0008-5472.CAN-20-1659
- Dzutsev A, Badger JH, Perez-Chanona E, Roy S, Salcedo R, Smith CK, Trinchieri G. Microbes and cancer. Annu Rev Immunol. 2017 Apr 26;35(1):199–228. https://doi.org/10.1146/annurev-immunol-051116-052133
- Eslami-SZ, Majidzadeh-AK, Halvaei S, Babapirali F, Esmaeili R. Microbiome and breast cancer: new role for an ancient population. Front Oncol. 2020 Feb 12;10:120. https://doi.org/10.3389/fonc.2020.00120
- Ferreira RM, Pereira-Marques J, Pinto-Ribeiro I, Costa JL, Carneiro F, Machado JC, Figueiredo C. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut. 2018 Feb;67(2):226–236. https://doi.org/10.1136/gutjnl-2017-314205
- Flores R, Shi J, Fuhrman B, Xu X, Veenstra TD, Gail MH, Gajer P, Ravel J, Goedert JJ. Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J Transl Med. 2012 Dec;10(1):253. https://doi.org/10.1186/1479-5876-10-253
- García Rodríguez LA, González-Pérez A. Use of antibiotics and risk of breast cancer. Am J Epidemiol. 2005 Apr 01;161(7):616–619. https://doi.org/10.1093/aje/kwi087
- Goedert JJ, Hua X, Bielecka A, Okayasu I, Milne GL, Jones GS, Fujiwara M, Sinha R, Wan Y, Xu X, et al. Postmenopausal breast cancer and oestrogen associations with the IgA-coated and IgA-non-coated faecal microbiota. Br J Cancer. 2018 Feb 20;118(4):471–479. https://doi.org/10.1038/bjc.2017.435
- Goedert JJ, Jones G, Hua X, Xu X, Yu G, Flores R, Falk RT, Gail MH, Shi J, Ravel J, et al. Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study. JNCI: J Natl Cancer Inst. 2015 Aug;107(8):djv147. https://doi.org/10.1093/jnci/djv147
- Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2018 Jan 05;359(6371):97–103. https://doi.org/10.1126/science.aan4236
- Goubet AG, Wheeler R, Fluckiger A, Qu B, Lemaître F, Iribarren K, Mondragón L, Tidjani Alou M, Pizzato E, Durand S, et al. Multifaceted modes of action of the anticancer probiotic Enterococcus hirae. Cell Death Differ. 2021 Jul;28(7):2276–2295. https://doi.org/10.1038/s41418-021-00753-8
- Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005 Jul 21;353(3):229–237. https://doi.org/10.1056/NEJMoa044383
- Hieken TJ, Chen J, Hoskin TL, Walther-Antonio M, Johnson S, Ramaker S, Xiao J, Radisky DC, Knutson KL, Kalari KR, et al. The microbiome of aseptically collected human breast tissue in benign and malignant disease. Sci Rep. 2016 Nov;6(1):30751. https://doi.org/10.1038/srep30751
- Ingman WV. The gut microbiome: a new player in breast cancer metastasis. Cancer Res. 2019 Jul 15;79(14):3539–3541. https://doi.org/10.1158/0008-5472.CAN-19-1698
- Jiang Y, Fan L. The effect of Poria cocos ethanol extract on the intestinal barrier function and intestinal microbiota in mice with breast cancer. J Ethnopharmacol. 2021 Feb;266:113456. https://doi.org/10.1016/j.jep.2020.113456
- Johansson A, Christakou AE, Iftimi A, Eriksson M, Tapia J, Skoog L, Benz CC, Rodriguez-Wallberg KA, Hall P, Czene K, et al. Characterization of benign breast diseases and association with age, hormonal factors, and family history of breast cancer among women in Sweden. JAMA Netw Open. 2021 Jun 01;4(6):e2114716. https://doi.org/10.1001/jamanetworkopen.2021.14716
- Katagiri S, Shiba T, Tohara H, Yamaguchi K, Hara K, Nakagawa K, Komatsu K, Watanabe K, Ohsugi Y, Maekawa S, et al. Re-initiation of oral food intake following enteral nutrition alters oral and gut microbiota communities. Front Cell Infect Microbiol. 2019 Dec 20; 9:434. https://doi.org/10.3389/fcimb.2019.00434
- Kovács T, Mikó E, Ujlaki G, Yousef H, Csontos V, Uray K, Bai P. The involvement of oncobiosis and bacterial metabolite signaling in metastasis formation in breast cancer. Cancer Metastasis Rev. 2021 Dec;40(4):1223–1249. https://doi.org/10.1007/s10555-021-10013-3
- Kwa M, Plottel CS, Blaser MJ, Adams S. The intestinal microbiome and estrogen receptor-positive female breast cancer. J Natl Cancer Inst. 2016 Apr 22;108(8). https://doi.org/10.1093/jnci/djw029
- Laborda-Illanes A, Sanchez-Alcoholado L, Dominguez-Recio ME, Jimenez-Rodriguez B, Lavado R, Comino-Méndez I, Alba E, Queipo-Ortuño MI. Breast and gut microbiota action mechanisms in breast cancer pathogenesis and treatment. Cancers (Basel). 2020 Aug 31;12(9):2465. https://doi.org/10.3390/cancers12092465
- Lakritz JR, Poutahidis T, Levkovich T, Varian BJ, Ibrahim YM, Chatzigiagkos A, Mirabal S, Alm EJ, Erdman SE. Beneficial bacteria stimulate host immune cells to counteract dietary and genetic predisposition to mammary cancer in mice. Int J Cancer. 2014 Aug; 135(3):529–540. https://doi.org/10.1002/ijc.28702
- Lakritz JR, Poutahidis T, Mirabal S, Varian BJ, Levkovich T, Ibrahim YM, Ward JM, Teng EC, Fisher B, Parry N, et al. Gut bacteria require neutrophils to promote mammary tumorigenesis. Oncotarget. 2015 Apr 20;6(11):9387–9396. https://doi.org/10.18632/oncotarget.3328
- Larsen JM. The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology. 2017 Aug; 151(4):363–374. https://doi.org/10.1111/imm.12760
- Lasry A, Zinger A, Ben-Neriah Y. Inflammatory networks underlying colorectal cancer. Nat Immunol. 2016 Mar;17(3):230–240. https://doi.org/10.1038/ni.3384
- Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto JM, Kennedy S, et al.; MetaHIT consortium. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013 Aug 29;500(7464):541–546. https://doi.org/10.1038/nature12506
- Margolis KL, Rodabough RJ, Thomson CA, Lopez AM, McTiernan A; Women’s Health Initiative Research Group. Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women. Arch Intern Med. 2007 Sep 24;167(17):1837–1844. https://doi.org/10.1001/archinte.167.17.1837
- Méndez Utz VE, Pérez Visñuk D, Perdigón G, de Moreno de LeBlanc A. Milk fermented by Lactobacillus casei CRL431 administered as an immune adjuvant in models of breast cancer and metastasis under chemotherapy. Appl Microbiol Biotechnol. 2021 Jan; 105(1):327–340. https://doi.org/10.1007/s00253-020-11007-x
- Meng S, Chen B, Yang J, Wang J, Zhu D, Meng Q, Zhang L. Study of microbiomes in aseptically collected samples of human breast tissue using needle biopsy and the potential role of in situ tissue microbiomes for promoting malignancy. Front Oncol. 2018 Aug 17;8:318. https://doi.org/10.3389/fonc.2018.00318
- Newman TM, Vitolins MZ, Cook KL. From the table to the tumor: the role of mediterranean and western dietary patterns in shifting microbial-mediated signaling to impact breast cancer risk. Nutrients. 2019 Oct 24;11(11):2565. https://doi.org/10.3390/nu11112565
- Patel SH, Vaidya YH, Patel RJ, Pandit RJ, Joshi CG, Kunjadiya AP. Culture independent assessment of human milk microbial community in lactational mastitis. Sci Rep. 2017 Dec;7(1):7804. https://doi.org/10.1038/s41598-017-08451-7
- Pellegrini M, Ippolito M, Monge T, Violi R, Cappello P, Ferrocino I, Cocolin LS, De Francesco A, Bo S, Finocchiaro C. Gut microbiota composition after diet and probiotics in overweight breast cancer survivors: a randomized open-label pilot intervention trial. Nutrition. 2020 Jun;74:110749. https://doi.org/10.1016/j.nut.2020.110749
- Pourbaferani M, Modiri S, Norouzy A, Maleki H, Heidari M, Alidoust L, Derakhshan V, Zahiri HS, Noghabi KA. A newly characterized potentially probiotic strain, Lactobacillus brevis MK05, and the toxicity effects of its secretory proteins against MCF-7 breast cancer cells. Probiotics Antimicrob Proteins. 2021 Aug;13(4):982–992. https://doi.org/10.1007/s12602-021-09766-8
- Rao VP, Poutahidis T, Fox JG, Erdman SE. Breast cancer: should gastrointestinal bacteria be on our radar screen? Cancer Res. 2007 Feb 01;67(3):847–850. https://doi.org/10.1158/0008-5472.CAN-06-3468
- Rutkowski MR, Stephen TL, Svoronos N, Allegrezza MJ, Tesone AJ, Perales-Puchalt A, Brencicova E, Escovar-Fadul X, Nguyen JM, Cadungog MG, et al. Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation. Cancer Cell. 2015 Jan;27(1):27–40. https://doi.org/10.1016/j.ccell.2014.11.009
- Sergentanis TN, Zagouri F, Zografos GC. Is antibiotic use a risk factor for breast cancer? A meta-analysis. Pharmacoepidemiol Drug Saf. 2010 Nov;19(11):1101–1107. https://doi.org/10.1002/pds.1986
- Shi J, Geng C, Sang M, Gao W, Li S, Yang S, Li Z. Effect of gastrointestinal microbiome and its diversity on the expression of tumor-infiltrating lymphocytes in breast cancer. Oncol Lett. 2019 Jun;17(6):5050–5056. https://doi.org/10.3892/ol.2019.10187
- Shimizu J, Kubota T, Takada E, Takai K, Fujiwara N, Arimitsu N, Ueda Y, Wakisaka S, Suzuki T, Suzuki N. Relative abundance of Megamonas hypermegale and Butyrivibrio species decreased in the intestine and its possible association with the T cell aberration by metabolite alteration in patients with Behcet’s disease (210 characters). Clin Rheumatol. 2019 May;38(5):1437–1445. https://doi.org/10.1007/s10067-018-04419-8
- Simin J, Tamimi RM, Engstrand L, Callens S, Brusselaers N. Antibiotic use and the risk of breast cancer: a systematic review and dose-response meta-analysis. Pharmacol Res. 2020 Oct;160:105072. https://doi.org/10.1016/j.phrs.2020.105072
- Sørensen HT, Skriver MV, Friis S, McLaughlin JK, Blot WJ, Baron JA. Use of antibiotics and risk of breast cancer: a population-based case-control study. Br J Cancer. 2005 Feb;92(3):594–596. https://doi.org/10.1038/sj.bjc.6602313
- Terrisse S, Derosa L, Iebba V, Ghiringhelli F, Vaz-Luis I, Kroemer G, Fidelle M, Christodoulidis S, Segata N, Thomas AM, et al. Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment. Cell Death Differ. 2021 Sep; 28(9):2778–2796. https://doi.org/10.1038/s41418-021-00784-1
- Urbaniak C, Cummins J, Brackstone M, Macklaim JM, Gloor GB, Baban CK, Scott L, O’Hanlon DM, Burton JP, Francis KP, et al. Microbiota of human breast tissue. Appl Environ Microbiol. 2014 May 15;80(10):3007–3014. https://doi.org/10.1128/AEM.00242-14
- Urbaniak C, Gloor GB, Brackstone M, Scott L, Tangney M, Reid G. The microbiota of breast tissue and its association with breast cancer. Appl Environ Microbiol. 2016 Aug 15;82(16):5039–5048. https://doi.org/10.1128/AEM.01235-16
- Warren RL, Freeman DJ, Pleasance S, Watson P, Moore RA, Cochrane K, Allen-Vercoe E, Holt RA. Co-occurrence of anaerobic bacteria in colorectal carcinomas. Microbiome. 2013 Dec; 1(1):16. https://doi.org/10.1186/2049-2618-1-16
- Watts AM, West NP, Zhang P, Smith PK, Cripps AW, Cox AJ. The gut microbiome of adults with allergic rhinitis is characterised by reduced diversity and an altered abundance of key microbial taxa compared to controls. Int Arch Allergy Immunol. 2021;182(2):94–105. https://doi.org/10.1159/000510536
- Wirtz HS, Buist DSM, Gralow JR, Barlow WE, Gray S, Chubak J, Yu O, Bowles EJA, Fujii M, Boudreau DM. Frequent antibiotic use and second breast cancer events. Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1588–1599. https://doi.org/10.1158/1055-9965.EPI-13-0454
- Worsham MJ, Raju U, Lu M, Kapke A, Botttrell A, Cheng J, Shah V, Savera A, Wolman SR. Risk factors for breast cancer from benign breast disease in a diverse population. Breast Cancer Res Treat. 2009 Nov; 118(1):1–7. https://doi.org/10.1007/s10549-008-0198-8
- Wu AH, Tseng C, Vigen C, Yu Y, Cozen W, Garcia AA, Spicer D. Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study. Breast Cancer Res Treat. 2020 Jul;182(2):451–463. https://doi.org/10.1007/s10549-020-05702-6
- Yang P, Wang Z, Peng Q, Lian W, Chen D. Comparison of the gut microbiota in patients with benign and malignant breast tumors: a pilot study. Evol Bioinform Online. 2021 Jan;17: 11769343211057573. https://doi.org/10.1177/11769343211057573
- Zhu B, Wang X, Li L. Human gut microbiome: the second genome of human body. Protein Cell. 2010 Aug; 1(8):718–725. https://doi.org/10.1007/s13238-010-0093-z
- Zhu J, Liao M, Yao Z, Liang W, Li Q, Liu J, Yang H, Ji Y, Wei W, Tan A, et al. Breast cancer in postmenopausal women is associated with an altered gut metagenome. Microbiome. 2018 Dec;6(1):136. https://doi.org/10.1186/s40168-018-0515-3